Duquesne Family Office LLC

Institutional manager·Stanley Druckenmiller·CIK 0001536411
Latest Qtr return
+20.6%
SPY latest qtr
+10.8%
Alpha
+9.8ptsvs SPY
Invested
$4.2M
Holdings
58
Trades YTD
0

Performance · Fund vs SPY

Cumulative return · quarterly snapshots
+0%+70%Duquesne +67.2%SPY +36.5%Q1 '16Q2 '16Q3 '16Q4 '16

Coverage 92%. 4 quarters of 2016 measured against SPY adj-close benchmark.

EDITORIAL BRIEF · refreshed Jul 2, 2026

Why follow Duquesne Family Office LLC right now?

Duquesne Family Office LLC's Q1 2026 13F (period ending 2025-12-31) shows 58 positions with NTRA as the dominant holding at 13.6% of reported equity, followed by XLF at 7.1% and INSMED at 6.1%. The portfolio carries notable healthcare concentration across NTRA, INSMED, and TEVA, which together represent roughly 24% of disclosed holdings.

Notable additions include AMZN (+440% shares quarter-over-quarter) and AAL (+378%), with DAL also expanded +89%, increasing airline sector exposure. NAMS, a clinical-stage lipid-lowering company, grew +284%.

Q4 2025 reported alpha reached +9.8% against SPY (+10.8% vs +10.8% benchmark return of +10.8%); Q1 2025 showed +14.6% alpha. Past performance is not indicative of future results.

Generated from public SEC filings. Not investment advice.…

Read the full 114-word brief. Pro members get the complete editorial analysis on every curated manager, plus Sunday Pulse + Stock Picks.

Unlock with Pro — $9.99/mo

Top holdings · current snapshot

Source: 13F-HR
See all 58 holdings · Pro →

Recent trades · Last 90 days

No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.

Convergence · Duquesne Family Office LLC

Pattern cards reflect public SEC EDGAR and Congressional filing data only. Detection uses filing dates; trade execution dates may differ. Past convergence patterns do not predict future returns. Nothing here is investment advice.

Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 11:06 UTC.